Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
A multi-omics features-based approach integrating immunogenicity and inflammation enhances immunotherapy benefit in clear cell renal cell carcinoma.
PMID 41640425 · PMC12864441 · Frontiers in cell and developmental biology · 2025 · 7 claims · 8 setups
The TIs-ML multi-omics model predicts ICB response/survival in ccRCC with superior accuracy (AUC > 0.997) compared to single biomarkers like PD-L1 and TMB
-
Full-text index only
Radiogenomics predicts immune microenvironment heterogeneity and response to combination immunotherapy in hepatocellular carcinoma.
PMID 41555384 · PMC12895822 · Journal of translational medicine · 2026 · 8 claims · 8 setups
A parsimonious 2-gene immune-related signature (IRS = 0.425×KPNA2 + 0.302×SMG5) is significantly associated with immune heterogeneity and response to ICI plus anti-angiogenic combination therapy in HCC
-
Full-text index only
A cross-scale multimodal framework identifies clinically actionable immunotherapy biomarkers in melanoma through bulk to single-cell and spatial transcriptomics integration.
PMID 41840725 · PMC13104449 · Human genomics · 2026 · 7 claims · 8 setups
Multi-omics consensus clustering (MOVICS) identifies two distinct SKCM molecular subtypes, CS1 and CS2
-
Full-text index only
Integration of aged brain multi-omics reveals cross-system mechanisms underlying Alzheimer's disease heterogeneity.
PMID 41950003 · PMC13244359 · Cell reports · 2026 · 8 claims · 7 setups
Multi-omics factor analysis (MOFA) integrating seven omics views from 1,358 ROS/MAP participants identifies cross-omics biological factors relating to AD phenotypes.
-
Full-text index only
Multi-omics feature engineering driven by biomedical foundation models improves drug response prediction for inflammatory bowel disease patients.
PMID 41844950 · PMC13129071 · Scientific reports · 2026 · 8 claims · 7 setups
FM (MAMMAL)-derived drug-target binding affinity (BA) inference can be used to rank/select biologically relevant protein targets and their associated genes/SNPs for a drug of interest without knowledge of protein structure or active sites
-
Full-text index only
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome.
PMID 41956098 · PMC7619149 · Immunity · 2026 · 8 claims · 8 setups
Reduced NMD activity (lower NMD score) predicts improved CPI response across >1,000 patients, independent of TMB or tumor type
-
Full-text index only
Immune profiling in a living human recipient of a gene-edited pig kidney.
PMID 41507576 · PMC12823403 · Nature medicine · 2026 · 8 claims · 8 setups
Xenograft experienced early T cell-mediated rejection (Banff grade 2A) within 1 week post-transplant despite profound circulating T cell depletion, likely driven by subtherapeutic immunosuppression and residual CD8+ T cells in lymph nodes.
-
Full-text index only
A unified framework for correcting batch effects and integrating multi-omics data.
PMID 41786846 · PMC13079841 · Scientific reports · 2026 · 7 claims · 6 setups
MoDAmix, a four-stage domain adaptation framework (pre-training, single-omics adversarial adaptation, multi-omics adversarial alignment, semi-supervised class alignment), unifies batch correction across multiple omics layers.
-
Full-text index only
Predicting enhancer-gene links from single-cell multi-omics data by integrating prior Hi-C information.
PMID 42100854 · PMC13229940 · Nucleic acids research · 2026 · 8 claims · 6 setups
SCEG-HiC, a weighted graphical lasso (wglasso) method, predicts enhancer-gene links from single-cell multi-omics data by integrating bulk average Hi-C as a prior penalty matrix
-
Has reproduction · 80
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
PMID 36928603 · PMC10101853 · Nature genetics · 2023 · 8 claims · 6 setups
The WHO histopathological classification of MPM accounts for only up to ~10% of interpatient molecular differences
-
Full-text index only
Discovery of key regulators in classical monocyte phenotypes linked to COVID-19 severity using single-cell multi-omics sequencing.
PMID 41732268 · PMC12925236 · iScience · 2026 · 8 claims · 8 setups
Two severity-associated classical monocyte (cMono) subtypes, IL7R+ and CD163+, exist with distinct transcriptional and epigenetic landscapes.